KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $790000.0.

  • Staar Surgical's Interest & Investment Income fell 4385.22% to $790000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1621.26%. This contributed to the annual value of $5.9 million for FY2024, which is 1538.79% down from last year.
  • Latest data reveals that Staar Surgical reported Interest & Investment Income of $790000.0 as of Q3 2025, which was down 4385.22% from $1.4 million recorded in Q2 2025.
  • Staar Surgical's Interest & Investment Income's 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of -$558000.0 in Q1 2021.
  • For the 5-year period, Staar Surgical's Interest & Investment Income averaged around $913550.0, with its median value being $1.4 million (2025).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 240000.0% in 2021, then soared by 5056666.67% in 2022.
  • Staar Surgical's Interest & Investment Income (Quarter) stood at -$3000.0 in 2021, then surged by 50566.67% to $1.5 million in 2022, then grew by 12.22% to $1.7 million in 2023, then dropped by 8.59% to $1.6 million in 2024, then plummeted by 49.13% to $790000.0 in 2025.
  • Its Interest & Investment Income was $790000.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $1.4 million in Q1 2025.